User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 7 results.
    • Journal article
    EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
    Bertsias, G. K. Ioannidis, J. P. A. Boletis, J. Bombardieri, S. Cervera, R. Dostal, C. Font, J. Gilboe, I. M. Houssiau, Frédéric[UCL] Huizinga, T. Isenberg, D. Kallenberg, C. G. M. Khamashta, M. Piette, J. C. Schneider, M. Smolen, J. Sturfelt, G. Tincani, A. van Vollenhoven, R. Boumpas, D. T. Gordon, C. (2009) Annals of the Rheumatic Diseases — Vol. 68, no. 4, p. 477-483 (2009)
    • Speech
    Reduction in radiographic progression in the hands and feet of patients with early rheumatoid arthritis after receiving infliximab in combination with methotrexate
    Van der Heijde, D Durez, Patrick[UCL] Emery, P. Bathon, JM Maini, RN Westhovens, Rene[UCL] Han, J. St Clair, E Smolen, J. (2005) Annual European Congress of Rheumatology — Vienna (Austria)
    • Speech
    Effect of infliximab and methotrexate on radiographic progression in patients with early rheumatoid arthritis
    Van der Heijde, D Durez, Patrick[UCL] Emery, P. Keystone, E Maini, RN Kalden, JR Schiff, M. Han, J. Baker, D. Smolen, J. St Clair, E (2005) Annual European Congress of Rheumatology — Vienna (Austria)
    • Journal article
    EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
    Bertsias, G. Ioannidis, J. P. A. Boletis, J. Bombardieri, S. Cervera, R. Dostal, C. Font, J. Gilboe, I. M. Houssiau, Frédéric[UCL] Huizinga, T. Isenberg, D. Kallenberg, C. G. M. Khamashta, M. Piette, J. C. Schneider, M. Smolen, J. Sturfelt, G. Tincani, A. van Vollenhoven, R. Gordon, C. Boumpas, D. T. (2008) Annals of the Rheumatic Diseases — Vol. 67, no. 2, p. 195-205 (2008)
    • Speech
    The effect of infliximab therapy on the prevention of new erosions in patients with early rheumatoid arthritis.
    Smolen, J. van der Heijde, D Devogelaer, Jean-Pierre[UCL] Han, CL Bala, M Baker, D. Han, J. St Clair, EW (2004) 68th Annual Scientific Meeting of the American-College-of-Rheumatology/39th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — San Antonio (Tx)
    • Speech
    Infliximab therapy leads to clinical and radiographic benefits in early rheumatoid arthritis patients receiving optimum methotrexate dose
    Bathon, J. Devogelaer, Jean-Pierre[UCL] Kalden, JR Shiff, M Emery, P. Maini, RN van der Heijde, D Keystone, E Baker, D. Patel, K Han, J. Smolen, J. Clair, EWS (2004) Annual European Congress of Rheumatology (EULAR 2004) — Berlin (Germany)
    • Speech
    Clinical and genetic associations of anti-GM1 antibodies in a large series of European patients with SLE
    Galeazzi, M. Houssiau, Frédéric[UCL] Sebastiani, GD Annunziata, P Mathieu, A. Scorza, R Papasteriades, C Smolen, J. Cervera, R. Campanella, V Marcolongo, R (1998) —